| An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis. | |
| | |
MedLine Citation:
|
PMID: 14530867 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To determine whether a regimen of cyclosporine (CSA) and methotrexate (MTX), or CSA and hydroxychloroquine (HCQ) introduced in early rheumatoid arthritis (RA) can produce a significant improvement in clinical outcome and/or retard radiographic damage in comparison with standard monotherapy with CSA alone. METHODS: One hundred five patients with active RA of less than 36 months duration, who had never previously been treated with immunosuppressive agents, were included in a 12-month, multi-center, open, randomized trial. Patients who fulfilled the criteria for early severe RA were randomized to receive either combination therapy (CSA + MTX n = 34, CSA + HCQ n = 35) or CSA alone (n = 36). RESULTS: CSA + MTX was more effective than the other two treatment groups in controlling RA symptoms. CSA+MTX did not show a significant radiographic progression according to Larsen-Dale (0.90 +/- 3.89 compared to baseline values, P > 0.05); moreover, patients treated with CSA alone or CSA+HCQ showed a significant worsening of Larsen-Dale score (2.91 +/- 5.99 and 2.97 +/- 4.28 respectively vs baseline values, P < 0.05), although not significant when compared with the CSA + HCQ group (P = 0.56 and 0.39, respectively). CONCLUSIONS: This trial indicated that CSA+MTX was more effective than the other two treatments in improving clinical data and inhibiting radiographic progression, although the differences were not significant in this relatively small study. However, the difference was significant in favor of CSA + MTX regarding ACR 50% response. |
| | |
Authors:
|
Piercarlo Sarzi-Puttini; Enzo D'Ingianna; Mario Fumagalli; Magda Scarpellini; Tania Fiorini; Enrico Luigi Chérié-Lignière; Benedetta Panni; Franco Fiorentini; Vincenzo Corbelli; Nebiat Belai Beyene; Claudio Mastaglio; Carlo Severi; Maurizio Locati; Marco Cazzola; Guido Menozzi; Giuseppe Monti; Francesco Saccardo; Giuseppina Alfieri; Fabiola Atzeni |
Related Documents
:
|
19916847 - The effect of rhythmic auditory stimulation (ras) on physical therapy outcomes for pati... 2084237 - Radiologic progression during intramuscular methotrexate treatment of rheumatoid arthri... 23208057 - In-stent stenosis following stent-assisted coiling: incidence, predictors and clinical ... 15361377 - Better efficacy of methotrexate given by intramuscular injection than orally in patient... 3535967 - Prophylaxis with tinidazole of infection in major head and neck surgery for malignant d... 20690247 - Erectile dysfunction in older male stroke patients: correlation between side of hemiple... |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial Date: 2003-10-07 |
Journal Detail:
|
Title: Rheumatology international Volume: 25 ISSN: 0172-8172 ISO Abbreviation: Rheumatol. Int. Publication Date: 2005 Jan |
Date Detail:
|
Created Date: 2005-01-12 Completed Date: 2005-07-05 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8206885 Medline TA: Rheumatol Int Country: Germany |
Other Details:
|
Languages: eng Pagination: 15-22 Citation Subset: IM |
Affiliation:
|
Unità Operativa di Reumatologia, University Hospital L. Sacco, Via G. B. Grassi 74, 20157 Milan, Italy. Sarzi@tiscali.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antirheumatic Agents
/
therapeutic use* Arthritis, Rheumatoid / drug therapy*, pathology, physiopathology Arthrography Cyclosporine / therapeutic use* Drug Therapy, Combination Female Humans Hydroxychloroquine / therapeutic use* Immunosuppressive Agents / therapeutic use* Male Methotrexate / therapeutic use* Middle Aged Pain Measurement Severity of Illness Index Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antirheumatic Agents; 0/Immunosuppressive Agents; 118-42-3/Hydroxychloroquine; 59-05-2/Methotrexate; 59865-13-3/Cyclosporine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Increased sucrose permeability in Behçet's disease.
Next Document: Cloning and biochemical characterization of hexokinase from the methylotrophic yeast Hansenula polym...